Literature DB >> 33675529

Living Well with Kidney Disease by patient and care-partner empowerment: Kidney Health for Everyone Everywhere.

Kamyar Kalantar-Zadeh1, Philip Kam-Tao Li2, Ekamol Tantisattamo3, Latha Kumaraswami4, Vassilios Liakopoulos5, Siu-Fai Lui6, Ifeoma Ulasi7, Sharon Andreoli8, Alessandro Balducci9, Sophie Dupuis10, Tess Harris11, Anne Hradsky10, Richard Knight12, Sajay Kumar4, Maggie Ng13, Alice Poidevin10, Gamal Saadi14, Allison Tong15.   

Abstract

Living with chronic kidney disease (CKD) is associated with hardships for patients and their care-partners. Empowering patients and their care-partners, including family members or friends involved in their care, may help minimize the burden and consequences of CKD-related symptoms to enable life participation. There is a need to broaden the focus on living well with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 the year of "Living Well with Kidney Disease" in an effort to increase education and awareness on the important goal of patient empowerment and life participation. This calls for the development and implementation of validated patient-reported outcome measures to assess and address areas of life participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labeling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. Patients with kidney disease and their care-partners should feel supported to live well through concerted efforts by kidney care communities including during pandemics. In the overall wellness program for kidney disease patients, the need for prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after effective secondary and tertiary prevention programs, should be promoted. WKD 2021 continues to call for increased awareness of the importance of preventive measures throughout populations, professionals, and policy makers, applicable to both developed and developing countries.

Entities:  

Keywords:  Care-partner; Health policy; Low-middle-income countries; Patient empowerment

Year:  2021        PMID: 33675529      PMCID: PMC7936596          DOI: 10.1007/s40620-021-01000-6

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  1 in total

1.  Validation of a Histologic Scoring Index for C3 Glomerulopathy.

Authors:  Fernando Caravaca-Fontán; Hernando Trujillo; Marina Alonso; Montserrat Díaz-Encarnación; Virginia Cabello; Gema Ariceta; Luis F Quintana; Helena Marco; Xoana Barros; Natalia Ramos; Nuria Rodríguez-Mendiola; Sonia Cruz; Gema Fernández-Juárez; Eva Rodríguez; Francisco de la Cerda; Ana Pérez de José; Inmaculada López; Loreto Fernández; Vanessa Pérez Gómez; Ana Ávila; Luis Bravo; Javier Lumbreras; Natalia Allende; Maria Dolores Sanchez de la Nieta; Teresa Olea; Marta Melgosa; Ana Huerta; Rosa Miquel; Carmen Mon; Gloria Fraga; Alberto de Lorenzo; Juliana Draibe; Fayna González; Amir Shabaka; Maria Luisa Illescas; Consuelo Calvo; Victoria Oviedo; Iara Da Silva; Elena Goicoechea de Jorge; Francisco Caravaca; Manuel Praga
Journal:  Am J Kidney Dis       Date:  2020-12-22       Impact factor: 8.860

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.